Drug Database
Back to search

Belgium· BE-AMP-SAM545004-00

Dovato 50 mg - 300 mg

A lamivudine and dolutegravir product containing dolutegravir sodium, registered in Belgium by ViiV Healthcare. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR25

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedDovato 50 mg - 300 mgATCJ05AR25REGISTER NO.BE-AMP-SAM545004-00PACKS LISTED6CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dolutegravir sodiumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lamivudine and dolutegravir is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR25 (lamivudine and dolutegravir), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search lamivudine and dolutegravir products by name

Lamivudine and dolutegravir · ATC J05AR25

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Dolutegravir Sodium
Manufacturer
ViiV Healthcare
Country
Belgium (BE)
ATC code
J05AR25
ATC class
Lamivudine and dolutegravir
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 6

4 priced
  • be_apb
    4183596
    EUR 686.11
  • be_apb
    7726508
  • be_apb
    4751038
    EUR 686.11
  • be_apb
    5852322
    EUR 2036.36
  • be_apb
    3966579
    EUR 686.11
  • be_apb
    7727936

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lamivudine and dolutegravir in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lamivudine and dolutegravir products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Cyprus · Dogrivio
  • Iceland · Tivicay
  • Liechtenstein · Tivicay
  • Norway · Dolutegravir Teva, Tivicay
  • Sweden · Dogrivio, Dolutegravir Elpen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cd36da45-802b-4bc9-b150-81148b2434b3
GET /v1/drugs/cd36da45-802b-4bc9-b150-81148b2434b3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Dovato 50 mg - 300 mg",
  "name_fr": "Dovato 50 mg - 300 mg",
  "name_nl": "Dovato 50 mg - 300 mg",
  "amp_code": "SAM545004-00",
  "strengths": [
    "300.0000",
    "300.0000",
    "50.0000",
    "50.0000",
    "300.0000",
    "50.0000"
  ],
  "pack_count": 5,
  "substances": [
    "Dolutegravir Sodium",
    "Lamivudine",
    "Dolutegravir",
    "Mannitol",
    "Sodium Starch Glycolate",
    "Sodium Stearyl Fumarate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Lamivudine and Dolutegravir",
  "authorisation_numbers": [
    "EU/1/19/1370/001",
    "EU/1/19/1370/002",
    "EU/1/19/1370/003",
    "EU/1/19/1370/004"
  ]
}
API referenceMCP serverPlans

See everything about lamivudine and dolutegravir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console